公开(公告)号：US20100256118A1

公开(公告)日：2010-10-07

申请号：US12793649

申请日：2010-06-03

申请人： Yoshiaki ISOBE ,  Haruo Takaku ,  Haruhisa Ogita ,  Masanori Tobe ,  Ayumu Kurimoto ,  Tetsuhiro Ogino ,  Hitoshi Fujita

发明人： Yoshiaki ISOBE ,  Haruo Takaku ,  Haruhisa Ogita ,  Masanori Tobe ,  Ayumu Kurimoto ,  Tetsuhiro Ogino ,  Hitoshi Fujita

IPC分类号： A61K31/52 ,  C07D473/18 ,  A61K31/5377 ,  C07D473/24 ,  C07D473/16 ,  A61K31/55 ,  A61P11/06 ,  A61P17/00 ,  A61P37/02

CPC分类号： A61K31/5377 ,  A61K31/522 ,  A61K31/55

摘要： A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

摘要翻译： 用作局部给药的药物，其作为抗过敏剂有效。 用于局部给药的药物含有作为活性成分的由通式（1）表示的腺嘌呤化合物：[其中环A表示6至10元，单或双环，芳族烃或5至10元，单或双环， 含有1至3个选自0至2个氮原子，0或1个氧原子和0或1个硫原子的杂原子的芳族杂环; n为0〜2的整数， m为0〜2的整数; R代表卤代，（取代）烷基等; X1代表氧，硫，NR1（R1代表氢或烷基）或单键; Y1表示单键，亚烷基等; Y2表示单键，亚烷基等; Z表示亚烷基; 并且Q1和Q2中的至少一个表示-COOR 10（其中R 10表示（un）取代的烷基等）等）或该化合物的药学上可接受的盐。

公开(公告)号：US07080800B2

公开(公告)日：2006-07-25

申请号：US10298647

申请日：2002-11-19

申请人： Hiroaki Fujii ,  Koji Tanaka ,  Hitoshi Fujita ,  Koichi Furukawa

发明人： Hiroaki Fujii ,  Koji Tanaka ,  Hitoshi Fujita ,  Koichi Furukawa

IPC分类号： B65H75/48

CPC分类号： B60R22/44 ,  B60R2022/444 ,  B60R2022/4473

摘要： In controlling a seat belt retractor, at least one of signals selected from a state signal showing a movement of an occupant wearing a seat belt and an external signal obtained from detecting means installed in a vehicle during running thereof is received. Then, a rotational torque of a motor is selected to a predetermined reduction ratio corresponding to at least one of the state signal and the external signal from a plurality of torques. The motor is controlled to a predetermined torque, to thereby wind the webbing on the spool.

摘要翻译： 在控制座椅安全带卷收器时，接收从运行中安装在车辆中的检测装置获得的表示乘坐安全带的乘员的运动的状态信号和外部信号中选出的信号中的至少一种。 然后，根据多个转矩，将电动机的转矩选择为与至少一个状态信号和外部信号对应的预定减速比。 将电动机控制到预定的扭矩，从而将织带卷绕在卷轴上。

公开(公告)号：US20060153011A1

公开(公告)日：2006-07-13

申请号：US10541725

申请日：2003-12-12

申请人： Takashi Osa ,  Tomomi Murakami ,  Hitoshi Fujita

发明人： Takashi Osa ,  Tomomi Murakami ,  Hitoshi Fujita

IPC分类号： G04C3/00 ,  G04B1/00

CPC分类号： G04C10/02

摘要： According to the present invention, in an electronic timepiece with a solar cell comprising a timepiece movement, a timepiece case for housing the timepiece movement, a casing ring for housing and holding the timepiece movement in the timepiece case, a solar cell and a dial, the solar cell is disposed almost vertically to a solar cell positioning portion provided in the casing ring, and the solar cell has a slender strip shape formed on a flexible substrate. Consequently, a solar cell need not be disposed in a timepiece movement, and it is only necessary to change a casing ring as an external component even when a panel cover diameter is changed, allowing a common use of a timepiece movement. Further, a solar cell can be coiled to match the size of a casing ring when it is incorporated in the casing ring, therefore a common solar cell can be used despite a change in the panel cover diameter of the timepiece.

摘要翻译： 根据本发明，在具有包括钟表运动的太阳能电池的电子钟表中，用于容纳钟表运动的钟表壳体，用于容纳并保持钟表壳体中的钟表运动的壳环，太阳能电池和表盘， 太阳能电池几乎垂直于设置在壳环中的太阳能电池定位部分，并且太阳能电池具有形成在柔性基板上的细长条形状。 因此，太阳能电池不需要设置在钟表运动中，即使当面板盖直径变化时，仅需要改变作为外部部件的外壳，从而允许通常使用时计运动。 此外，当太阳能电池被并入壳体环中时，可以将太阳能电池盘卷以匹配壳体环的尺寸，因此，尽管钟表的面板盖直径发生变化，但是可以使用普通的太阳能电池。

公开(公告)号：US06598823B1

公开(公告)日：2003-07-29

申请号：US09697591

申请日：2000-10-27

申请人： Hiroaki Fujii ,  Hitoshi Fujita

发明人： Hiroaki Fujii ,  Hitoshi Fujita

IPC分类号： B65H7548

CPC分类号： B60R22/44 ,  B60R2022/444

摘要： To provide a seatbelt retractor in which wiring of lead wires in a cover is not required. Instead, a circuit board and the like can be positioned accurately, and the circuit board is sufficiently protected during the mounting of mechanical components. A circuit board is anchored to a groove of an inner cover mounted on a retainer so that the inner cover covers the circuit board at the periphery of the inner cover with rotation axles and pivot mating with mating holes, respectively, at ends thereof.

摘要翻译： 提供一种安全带卷收器，其中不需要在盖中的引线的布线。 相反，可以准确地定位电路板等，并且在安装机械部件期间电路板被充分地保护。 电路板被锚固到安装在保持器上的内盖的凹槽中，使得内盖分别在其端部处分别用旋转轴和配合孔枢转地与内盖的周边覆盖电路板。

公开(公告)号：US08148371B2

公开(公告)日：2012-04-03

申请号：US12793649

申请日：2010-06-03

申请人： Yoshiaki Isobe ,  Haruo Takaku ,  Haruhisa Ogita ,  Masanori Tobe ,  Ayumu Kurimoto ,  Tetsuhiro Ogino ,  Hitoshi Fujita

发明人： Yoshiaki Isobe ,  Haruo Takaku ,  Haruhisa Ogita ,  Masanori Tobe ,  Ayumu Kurimoto ,  Tetsuhiro Ogino ,  Hitoshi Fujita

IPC分类号： C07D473/18 ,  A61K31/522 ,  A61P37/08 ,  A61P11/06 ,  C07D473/40 ,  C07D473/16

CPC分类号： A61K31/5377 ,  A61K31/522 ,  A61K31/55

摘要： A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

摘要翻译： 用作局部给药的药物，其作为抗过敏剂有效。 用于局部给药的药物含有作为活性成分的由通式（1）表示的腺嘌呤化合物：[其中环A表示6至10元，单或双环，芳族烃或5至10元，单或双环， 含有1至3个选自0至2个氮原子，0或1个氧原子和0或1个硫原子的杂原子的芳族杂环; n为0〜2的整数， m为0〜2的整数; R代表卤代，（取代）烷基等; X1代表氧，硫，NR1（R1代表氢或烷基）或单键; Y1表示单键，亚烷基等; Y2表示单键，亚烷基等; Z表示亚烷基; 并且Q1和Q2中的至少一个表示-COOR 10（其中R 10表示（un）取代的烷基等）等）或该化合物的药学上可接受的盐。

公开(公告)号：US20060254408A1

公开(公告)日：2006-11-16

申请号：US11431582

申请日：2006-05-11

申请人： Hirofumi Yamaguchi ,  Hitoshi Fujita ,  Naoto Sawada

发明人： Hirofumi Yamaguchi ,  Hitoshi Fujita ,  Naoto Sawada

IPC分类号： G10H1/00

CPC分类号： G11B27/32 ,  G11B20/00253 ,  G11B20/00492 ,  G11B20/10527 ,  G11B2020/10546 ,  G11B2020/10666 ,  G11B2220/2537

摘要： The present invention comprises the steps of: when there is a change of music-piece, writing the last data of previous piece of music stored in a storage device to a recording medium; writing the front data of the next piece stored in the storage device; and executing file operation to change the music-piece after writing the front data of the next piece. By executing a part of the file operation to change the music-piece at other time than the change of music-piece, buffer referring time during the piece-change processing can be shortened.

摘要翻译： 本发明包括以下步骤：当存在音乐变化时，将存储在存储装置中的先前音乐的最后数据写入记录介质; 写入存储在存储装置中的下一个片段的前面数据; 并执行文件操作以在写入下一片的前面数据之后改变乐曲。 通过执行文件操作的一部分以在音乐片段的改变之外的其他时间改变音乐片段，可以缩短片段改变处理期间的缓冲器参考时间。

公开(公告)号：US20060052403A1

公开(公告)日：2006-03-09

申请号：US10528343

申请日：2003-09-26

申请人： Yoshiaki Isobe ,  Haruo Takaku ,  Haruhisa Ogita ,  Masanori Tobe ,  Ayumu Kurimoto ,  Tetsuhiro Ogino ,  Hitoshi Fujita

发明人： Yoshiaki Isobe ,  Haruo Takaku ,  Haruhisa Ogita ,  Masanori Tobe ,  Ayumu Kurimoto ,  Tetsuhiro Ogino ,  Hitoshi Fujita

IPC分类号： A61K31/52 ,  C07D473/12 ,  C07D473/14

CPC分类号： A61K31/5377 ,  A61K31/522 ,  A61K31/55

摘要： A drug for topically administration which is effective as an antiallergic agent. The drug for topically administration contains as an active ingredient an adenine compound represented by the general formula (1): [wherein ring A represents a 6 to 10 membered, mono or bicyclic, aromatic hydrocarbon or a 5 to 10 membered, mono or bicyclic, aromatic heterocycle containing one to three heteroatoms selected among 0 to 2 nitrogen atoms, 0 or 1 oxygen atom, and 0 or 1 sulfur atom; n is an integer of 0 to 2; m is an integer of 0 to 2; R represents halogeno, (un)substituted alkyl, etc.; X1 represents oxygen, sulfur, NR1 (R1 represents hydrogen or alkyl), or a single bond; Y1 represents a single bond, alkylene, etc.; Y2 represents a single bond, alkylene, etc.; Z represents alkylene; and at least one of Q1 and Q2 represents —COOR10 (wherein R10 represents (un)substituted alkyl, etc.), etc.] or a pharmaceutically acceptable salt of the compound.

摘要翻译： 用作局部给药的药物，其作为抗过敏剂有效。 用于局部给药的药物含有由通式（1）表示的腺嘌呤化合物作为活性成分：

公开(公告)号：US06302487B1

公开(公告)日：2001-10-16

申请号：US09665074

申请日：2000-09-19

申请人： Hitoshi Fujita ,  Etsunori Fujita ,  Yumi Ogura ,  Kazuyoshi Chizuka ,  Masaki Nishino ,  Akihito Asano ,  Seiji Kawasaki

发明人： Hitoshi Fujita ,  Etsunori Fujita ,  Yumi Ogura ,  Kazuyoshi Chizuka ,  Masaki Nishino ,  Akihito Asano ,  Seiji Kawasaki

IPC分类号： A47C702

CPC分类号： B60N2/70 ,  B60N2/5825

摘要： A seat includes a seat cushion frame, a seat back frame mounted to the seat cushion frame, and at least one three-dimensional net having upper and lower mesh layers and a pile layer made up of a large number of piles for connecting the upper and lower mesh layers. The three-dimensional net is stretched over substantially the entire region of the seat cushion frame and the seat back frame, thereby forming a seat cushion and a seat back. The three-dimensional net has a fixed end at a front end portion of the seat cushion and another fixed end at an upper end portion of the seat back. The seat also includes a first tension member attached to the three-dimensional net at a location adjacent to a central portion thereof for imparting tension thereto, and a second tension member attached to another portion of the three-dimensional net for fastening it to at least one of the seat cushion frame and the seat back frame.

摘要翻译： 座椅包括座垫框架，安装在座垫框架上的座椅靠背框架，以及至少一个具有上下网格层的三维网和由多个桩组成的绒头层，用于连接鞋面和 较低的网格层。 三维网在基本上在座垫框架和座椅靠背框架的整个区域上被拉伸，从而形成座垫和座椅靠背。 三维网在座垫的前端部具有固定端，在座椅靠背的上端部具有固定端。 所述座椅还包括第一张力构件，其在与其中心部分相邻的位置处附接到所述三维网，用于向其施加张力;以及第二张力构件，其附接到所述三维网的另一部分，用于将其紧固至少 座垫框架和座椅靠背框架之一。

公开(公告)号：US06265809B1

公开(公告)日：2001-07-24

申请号：US09390323

申请日：1999-09-07

申请人： Hiroaki Fujii ,  Ryuji Yano ,  Hitoshi Fujita ,  Kenji Kitazawa

发明人： Hiroaki Fujii ,  Ryuji Yano ,  Hitoshi Fujita ,  Kenji Kitazawa

IPC分类号： H02N200

CPC分类号： H02N2/147 ,  H02N2/142 ,  H02N2/163

摘要： A drive circuit for an ultrasonic motor includes a DC power source, a transformer for applying to the ultrasonic motor two phase high frequency voltage alternating currents having a predetermined phase difference for driving the ultrasonic motor, a switching device interposed between the DC power source and the transformer for allowing a direct current from the direct DC power source to flow to the transformer at a predetermined timing, and a CPU connected to the switching device for controlling the switching device at the predetermined timing. Thus, the alternating current having an optimum frequency can be reliably and easily obtained. The drive circuit may include a vibration attenuating device operated when the ultrasonic motor is stopped. As a result, vibration of a stator of the ultrasonic motor is gradually reduced.

摘要翻译： 一种用于超声波电动机的驱动电路，包括直流电源，用于向超声波电机施加的变压器，具有用于驱动超声波电动机的预定相位差的两相高频电压交流电;插入在直流电源和 用于允许来自直流DC电源的直流电流在预定定时流到变压器的变压器，以及连接到开关装置的CPU，用于在预定定时控制开关装置。 因此，可以可靠且容易地获得具有最佳频率的交流电。 驱动电路可以包括当超声波马达停止时操作的振动衰减装置。 结果，超声波马达的定子的振动逐渐减小。

公开(公告)号：US5948786A

公开(公告)日：1999-09-07

申请号：US69085

申请日：1998-04-29

申请人： Norio Fujiwara ,  Yutaka Ueda ,  Shinobu Murata ,  Fumiyo Hirota ,  Hajime Kawakami ,  Hitoshi Fujita

发明人： Norio Fujiwara ,  Yutaka Ueda ,  Shinobu Murata ,  Fumiyo Hirota ,  Hajime Kawakami ,  Hitoshi Fujita

IPC分类号： A61K31/506 ,  A61K31/517 ,  C07D401/04 ,  C07D401/14 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14 ,  A61K31/505 ,  C07D239/02 ,  C07D401/00

CPC分类号： C07D401/04 ,  A61K31/506 ,  A61K31/517 ,  C07D401/14 ,  C07D405/14 ,  C07D413/14 ,  C07D417/14

摘要： A compound of formula (1) ##STR1## wherein X.sup.1 is amino or hydroxyl, X.sup.2 is carbonyl and the like R.sup.1 is an alkyl, an aryl and the like, R.sup.2 is hydrogen and the like, and R.sup.3 is an alkyl and the like, or a pharmaceutical acceptable salt thereof is effective for inibiting the production and/or secretion of tumor necrosis factor in a patient in need of such inhibition.

摘要翻译： 式（1）的化合物，其中X 1为氨基或羟基，X 2为羰基等，R 1为烷基，芳基等，R 2为氢等，R 3为烷基等，或药物 其可接受的盐对于在需要这种抑制的患者中抑制肿瘤坏死因子的产生和/或分泌是有效的。